Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study
Introduction: Trastuzumab emtansine (T-DM1) is one of the effective treatment options in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients. In this study, we aimed to find the effect of T-DM1 on survival, its tolerability and prognostic factors of T-DM1 treatment. Mater...
Na minha lista:
| Udgivet i: | Iberoamerican Journal of Medicine |
|---|---|
| Principais autores: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hospital San Pedro
2022
|
| Fag: | |
| Online adgang: | https://www.redalyc.org/articulo.oa?id=692072548004 https://www.redalyc.org/journal/6920/692072548004/ https://www.redalyc.org/journal/6920/692072548004/html/ https://www.redalyc.org/journal/6920/692072548004/692072548004.epub https://www.redalyc.org/journal/6920/692072548004/movil https://doi.org/10.53986/ibjm.2022.0033 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
